{
  "meta": {
    "title": "Tolerance_Autoimmune_Disorders",
    "url": "https://brainandscalpel.vercel.app/tolerance-autoimmune-disorders-b3975c07.html",
    "scrapedAt": "2025-11-29T18:32:13.932Z"
  },
  "questions": [
    {
      "id": 14169,
      "choices": [
        {
          "id": 56637,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Affects males and females equally </span></span></span></p>"
        },
        {
          "id": 56638,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal and CNS involvement is uncommon</span></span></span></p>"
        },
        {
          "id": 56639,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti histone antibody levels are low </span></span></span></p>"
        },
        {
          "id": 56640,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The disease remits after withdrawal of the offending drug</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In evaluating a patient with a suspected diagnosis of drug-induced lupus erythematosus (DILE), which of the following statements is INCORRECT?</span></span></span></p>",
      "unique_key": "Q2833636",
      "question_audio": null,
      "question_video": null,
      "map_id": 31881,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Anti histone antibody levels are low</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-histone antibody levels are low:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is<strong> incorrect</strong>. In DILE, there is typically a<strong> high level of anti-histone antibodies, </strong>which is a<strong> hallmark of the condition </strong>and helps differentiate it from <strong>idiopathic SLE</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Affects males and females equally:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> DILE does not demonstrate the same <strong>female predominance </strong>as systemic lupus erythematosus (SLE). Both males and females are affected equally.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Renal and CNS involvement is uncommon:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Unlike SLE, DILE typically <strong>spares the kidneys and central nervous system</strong>, with these organ systems being less commonly involved.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: The disease remits after withdrawal of the offending drug:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> One of the key features of <strong>DILE </strong>is that symptoms usually resolve upon <strong>withdrawal of the offending drug</strong>, differentiating it from<strong> idiopathic SLE</strong>, which is a chronic condition.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Drug-induced lupus erythematosus </strong>is characterized by <strong>high levels of anti-histone antibodies</strong>, and unlike<strong> idiopathic SLE</strong>, it affects <strong>males and females equally, renal and CNS involvement are uncommon</strong>, and the condition usually remits after<strong> withdrawal of the offending drug</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference Robbins 10<sup>th</sup>/229</span></strong></span></span></p>",
      "correct_choice_id": 56639,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14199,
      "choices": [
        {
          "id": 56757,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lymphocyte</span></span></span></p>"
        },
        {
          "id": 56758,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endothelial cell</span></span></span></p>"
        },
        {
          "id": 56759,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Eosinophil</span></span></span></p>"
        },
        {
          "id": 56760,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neutrophil </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the context of systemic lupus erythematosus (SLE), which cell type is historically known for its role in the formation of lupus erythematosus (LE) cells, a phenomenon once used in the diagnosis of SLE?</span></span></span></p>",
      "unique_key": "Q3489530",
      "question_audio": null,
      "question_video": null,
      "map_id": 31880,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Neutrophil</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>lupus erythematosus (LE) cell </strong>is a phagocytic<strong> neutrophil or macrophage.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Nuclei of damaged cells </strong>react with <strong>ANAs, lose their chromatin pattern</strong>, and become <strong>homogeneous </strong>to produce<strong> LE bodies or hematoxylin bodies. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Phagocytic neutrophils or macrophages engulf the denatured nucleus </strong>of an injured cell. Demonstration of <strong>LE cells in vitro </strong>was used in the <strong>past for the diagnosis of SLE.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neutrophil:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The<strong> LE cell is a neutrophil</strong> that has<strong> phagocytosed the denatured nucleus of another cell</strong>, which is a characteristic feature seen in<strong> SLE.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Lymphocyte:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Lymphocytes are primarily involved in <strong>adaptive immune responses </strong>and are <strong>not typically phagocytic cells </strong>associated with the <strong>formation of LE cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Endothelial Cell:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Endothelial cells line <strong>blood vessels </strong>and are<strong> not involved in phagocytosis or the formation of LE cells</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Eosinophil:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Eosinophils are involved in <strong>allergic reactions and parasitic infections </strong>and do not form LE cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>LE cells are neutrophils or macrophages </strong>that have <strong>phagocytosed nuclear material</strong>. The demonstration of<strong> LE cells </strong>used to be a <strong>diagnostic test for SLE</strong>, reflecting the <strong>autoantibody-mediated destruction of cells </strong>leading to the presentation of <strong>nuclear antigens to these phagocytes. </strong></span></span></p>",
      "correct_choice_id": 56760,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14173,
      "choices": [
        {
          "id": 56653,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Molecular mimicry</span></span></span></p>"
        },
        {
          "id": 56654,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Polyclonal B cell activation </span></span></span></p>"
        },
        {
          "id": 56655,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Expressing sequestrated antigens </span></span></span></p>"
        },
        {
          "id": 56656,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antigenic cross reactivity </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a patient with Epstein-Barr virus (EBV) infection presenting with symptoms of autoimmunity, which mechanism is most likely contributing to the production of autoantibodies?</span></span></span></p>",
      "unique_key": "Q5493864",
      "question_audio": null,
      "question_video": null,
      "map_id": 31882,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Polyclonal B cell activation </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polyclonal B cell activation is caused by<strong> EBV and HIV </strong>resulting in production of <strong>autoantibodies. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polyclonal B cell activation:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> EBV infection </strong>is associated with <strong>polyclonal B cell activation. </strong>This uncontrolled activation can lead to the production of a<strong> wide array of antibodies, </strong>including <strong>autoantibodies.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Molecular Mimicry:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Molecular mimicry involves an<strong> infectious agent </strong>sharing <strong>epitopes </strong>with the host, leading to an <strong>immune response </strong>that <strong>cross-reacts with self-tissues. </strong>It is a known mechanism in certain <strong>autoimmune diseases </strong>but is not<strong> the primary mechanism </strong>by which <strong>EBV induces autoimmunity</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Expressing sequestrated antigens:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Sequestered antigens, normally hidden from the<strong> immune system,</strong> may become exposed due to t<strong>issue damage or other pathological processes</strong>, which could induce an <strong>autoimmune response.</strong> However, this is not typically associated with EBV infection.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Antigenic Cross-reactivity:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Antigenic cross-reactivity refers to an <strong>immune response against one antigen </strong>that reacts with a different but <strong>structurally similar antigen</strong>. While it can contribute to <strong>autoimmunity, </strong>it is not the primary process implicated in EBV-related autoimmunity.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The development of <strong>autoimmunity </strong>in the context of <strong>EBV infection </strong>is primarily associated with <strong>polyclonal B cell activation</strong>, leading to the production of <strong>autoantibodies. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup> 220) </span></span></em></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em> </em></strong></span></span></p>",
      "correct_choice_id": 56654,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14174,
      "choices": [
        {
          "id": 56657,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Systemic lupus erythematosus </span></span></span></p>"
        },
        {
          "id": 56658,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Scleroderma </span></span></p>"
        },
        {
          "id": 56659,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rheumatoid arthritis </span></span></span></p>"
        },
        {
          "id": 56660,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Histiocytosis </span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">14-year-old girl experiences episodes of pallor, pain, and cyanosis in her extremities upon exposure to cold. This condition often precedes the development of which systemic disease, known for its cutaneous manifestations and association with such vascular phenomena?</span></span></span></p>",
      "unique_key": "Q5103383",
      "question_audio": null,
      "question_video": null,
      "map_id": 31883,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Scleroderma </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Scleroderma (Systemic Sclerosis):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Scleroderma is well known for <strong>skin thickening and Raynaud&#39;s phenomenon, </strong>which is seen in virtually all patients and often precedes other symptoms, making it the most likely diagnosis associated with these symptoms.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Systemic Lupus Erythematosus (SLE):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> SLE is a <strong>chronic autoimmune disease </strong>with various clinical presentations,<strong> including Raynaud&#39;s phenomenon</strong>. However, SLE is characterized more by <strong>systemic symptoms </strong>and<strong> less by the cutaneous changes described.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Rheumatoid Arthritis (RA):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> RA is a <strong>chronic inflammatory disease </strong>primarily affecting the <strong>joints. </strong>While vascular symptoms can occur, they are <strong>not as prominent </strong>as the <strong>articular manifestations </strong>and not typically preceded by Raynaud&#39;s phenomenon.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Histiocytosis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Histiocytosis refers to a <strong>group of disorders </strong>characterized by the <strong>proliferation of histiocytes</strong>. It <strong>does not commonly </strong>present with<strong> Raynaud&#39;s phenomenon </strong>as an initial symptom.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Raynaud&#39;s phenomenon</strong>, characterized by episodic<strong> vasoconstriction of the arteries and arterioles of the extremities</strong>, is commonly associated with <strong>scleroderma </strong>and can precede <strong>other symptoms of the disease</strong>.&nbsp;</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 228-229) </span></span></em></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> </span></em></strong></span></span></p>",
      "correct_choice_id": 56658,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14183,
      "choices": [
        {
          "id": 56693,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PTPN22</span></span></span></p>"
        },
        {
          "id": 56694,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FAS</span></span></span></p>"
        },
        {
          "id": 56695,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FADD</span></span></span></p>"
        },
        {
          "id": 56696,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NOD like receptor</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents with chronic nonmalignant lymphoproliferation, autoimmune cytopenias, and a family history suggestive of a genetic syndrome. Genetic testing for which of the following genes is most likely to confirm the diagnosis?</span></span></span></p>",
      "unique_key": "Q5572089",
      "question_audio": null,
      "question_video": null,
      "map_id": 31877,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) FAS</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Self-reactive B cells </strong>are killed by<strong> Fas L on T cells engaging Fas on the B </strong>cells. Mutations in<strong> Fas or Fas L in mice and humans result in an autoimmune disease </strong>reminiscent of <strong>human SLE </strong>called the <strong><em>autoimmune lymphoproliferative syndrome (ALPS)</em></strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FAS:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The FAS gene encodes a <strong>cell surface receptor </strong>important for the <strong>apoptotic death of cells</strong>, including <strong>self-reactive B and T lymphocytes</strong>. Mutations in the FAS gene can<strong> lead to ALPS, </strong>characterized by accumulation of<strong> lymphocytes and increased risk of autoimmune disease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: PTPN22:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The PTPN22 gene encodes a<strong> tyrosine phosphatase involved in T cell receptor signaling. </strong>Mutations in this gene are associated with various autoimmune conditions, such as <strong>rheumatoid arthritis and type 1 diabetes</strong>, but not typically with <strong>autoimmune lymphoproliferative syndrome (ALPS).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: FADD:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> FADD is an <strong>adaptor protein </strong>involved in the <strong>apoptotic pathway</strong>. While important for <strong>apoptosis</strong>, known mutations in FADD are not classically associated with ALPS.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: NOD-like Receptor:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> NOD-like receptors are <strong>intracellular sensors of microbial motifs </strong>and<strong> cell stress </strong>that lead to <strong>inflammation, not apoptosis. </strong>Mutations in <strong>NOD-like receptors </strong>are associated with <strong>autoinflammatory syndromes, not ALPS.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Autoimmune lymphoproliferative syndrome (ALPS) </strong>is often caused by <strong>mutations in the FAS gene</strong>, which leads to defects in the <strong>apoptotic pathway, </strong>specifically in the <strong>programmed cell death of lymphocytes</strong>. This condition is characterized by<strong> autoimmune manifestations similar to systemic lupus erythematosus (SLE).</strong></span></span></p>",
      "correct_choice_id": 56694,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14196,
      "choices": [
        {
          "id": 56745,
          "text": "<p><span style=\"font-size:12pt;\">Positive SS-A</span></p>"
        },
        {
          "id": 56746,
          "text": "<p><span style=\"font-size:12pt;\">Positive anti-Smith antibody</span></p>"
        },
        {
          "id": 56747,
          "text": "<p><span style=\"font-size:12pt;\">Positive anti-cyclic citrullinated peptide (CCP-IgG)</span></p>"
        },
        {
          "id": 56748,
          "text": "<p><span style=\"font-size:12pt;\">Positive rheumatoid factor</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 26-year-old female presents with complaints of fatigue since 2 months. She has persistent arthralgia of the distal and proximal interphalangeal joints of both hands. Her physical examination is normal and there is no tenderness or deformity of the joints of the hands. A complete blood count is normal and her antinuclear antibody titer is elevated at 1:90. Which of the following additional tests would confirm the diagnosis of lupus erythematosus?</span></p>",
      "unique_key": "Q2855352",
      "question_audio": null,
      "question_video": null,
      "map_id": 31879,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Positive anti-Smith antibody</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Anti-Smith </strong>(B) is<strong> most specific</strong> for <strong>systemic lupus</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Positive anti-Smith antibody:</strong> The anti-Smith antibody is<strong> highly specific for SLE</strong>. This<strong> and a positive ANA </strong>would strongly support the<strong> diagnosis of SLE.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A: Positive SS-A:</strong> SS-A (or Ro) antibodies are associated with <strong>SLE </strong>(presence of the other issues like subacute cutaneous lupus)<strong> and Sjögren’s syndrome. </strong>Although they can be present in SLE, they are <strong>not specific to </strong>it, especially when considering the patient's clinical presentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C: Positive anti-cyclic citrullinated peptide (CCP-IgG):</strong> Anti-CCP IgG is<strong> highly specific for rheumatoid arthritis </strong>and is not typically used in the diagnosis of SLE.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D: Positive rheumatoid factor:</strong> Rheumatoid factor can be positive in a variety of<strong> rheumatologic diseases, including SLE</strong>, but it is <strong>not specific for SLE </strong>and is <strong>more commonly associated with rheumatoid arthritis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">When evaluating a patient for SLE, the <strong>anti-Smith antibody test is the most specific serological test </strong>and can <strong>confirm the diagnosis </strong>when the clinical picture is suggestive of the disease.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">ANA = screen → very sensitive but non-specific.</span></li><li><span style=\"font-size:12.0pt;\">Anti-Smith antibody - highly specific for SLE → confirms diagnosis when present.</span></li><li><span style=\"font-size:12.0pt;\">Anti-dsDNA is also specific and associated with lupus nephritis, but among the choices given, anti-Smith is the classic confirmatory antibody.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref Robbins 10<sup>th</sup>/ 222</strong></span></p>",
      "correct_choice_id": 56746,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14201,
      "choices": [
        {
          "id": 56765,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mikulicz syndrome</span></span></span></p>"
        },
        {
          "id": 56766,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Riedel thyroiditis</span></span></span></p>"
        },
        {
          "id": 56767,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Idiopathic retroperitoneal fibrosis</span></span></span></p>"
        },
        {
          "id": 56768,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Celiac disease </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents with enlargement of salivary glands, fibrosis of the pancreas, and increased serum levels of IgG4. Which condition from the following list is not typically associated with the spectrum of IgG4-related disease?</span></span></span></p>",
      "unique_key": "Q2160097",
      "question_audio": null,
      "question_video": null,
      "map_id": 31878,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Celiac disease</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Celiac disease is <strong>not an lgG4-related disease.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>IgG4-related disease (IgG4-RD) </strong>is a newly recognized constellation of disorders characterized by <strong>tissue infiltrates dominated by IgG4 antibody-producing plasma cells and lymphocytes, particularly T cells, storiform fibrosis, obliterative phlebitis</strong>, and usually <strong>increased serum IgG4</strong>. IgG4-RD spectrum includes:</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Celiac disease:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Celiac disease is an <strong>autoimmune </strong>condition triggered by <strong>ingestion of gluten </strong>in genetically<strong> susceptible </strong>individuals. It is <strong>not associated with IgG4-related disease</strong>, which is characterized by<strong> tissue infiltrates dominated by IgG4-positive plasma cells and lymphocytes, storiform fibrosis, and obliterative phlebitis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Mikulicz syndrome:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Mikulicz syndrome involves <strong>enlargement and fibrosis of the salivary and lacrimal glands </strong>and is a recognized part of the<strong> IgG4-related disease spectrum</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Riedel thyroiditis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Riedel thyroiditis is a<strong> fibrosing inflammatory process </strong>involving the<strong> thyroid gland</strong>, often associated with <strong>IgG4-related disease</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Idiopathic retroperitoneal fibrosis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Idiopathic retroperitoneal fibrosis is characterized by <strong>fibrous tissue </strong>in the <strong>retroperitoneum and can be associated with IgG4-related disease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>IgG4-related disease </strong>is a <strong>fibro-inflammatory </strong>condition characterized by several features, including <strong>tissue infiltration with IgG4-positive plasma cells</strong>. It <strong>does not encompass celiac disease</strong>, which has a d<strong>ifferent pathophysiology related to gluten sensitivity. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref Robbins 10<sup>th</sup>/232</span></span></strong></p>",
      "correct_choice_id": 56768,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}